Browsing: regulation

The development of dual agonists for the glucagon-like peptide-1 receptor (GLP-1R) and glucose-dependent insulinotropic polypeptide receptor (GIPR) has been a landmark moment in the treatment of type 2 diabetes and obesity. However, for reasons that are incompletely understood, in preclinical and clinical studies, adding either a GIPR agonist or GIPR antagonist to GLP-1R agonism causes…

The American College of Physicians (ACP) has recommended policy adoptions to modernize the regulation of dietary supplements in the US, saying that these products must be “more regulated to protect public health.” The organization’s position paper urges policymakers to strengthen the manufacturing and marketing of dietary supplements.